- Home
- ALHC
as 05-30-2025 4:00pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 3.7B | IPO Year: | 2021 |
| Target Price: | $17.45 | AVG Volume (30 days): | 3.6M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.05 - $21.06 | Next Earning Date: | 07-31-2025 |
| Revenue: | $3,001,892,000 | Revenue Growth: | 49.12% |
| Revenue Growth (this year): | 42.96% | Revenue Growth (next year): | 25.77% |
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. | ALHC | Director10% Owner | May 19 '25 | Sell | $15.28 | 17,000,000 | $259,760,000.00 | 44,302,175 | |
| General Atlantic (ALN HLTH), L.P. | ALHC | Director10% Owner | May 19 '25 | Sell | $15.28 | 17,000,000 | $259,760,000.00 | 44,302,175 | |
| Maroney Dawn Christine | ALHC | President | May 14 '25 | Sell | $14.95 | 30,000 | $446,237.01 | 2,102,899 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | May 1 '25 | Sell | $16.87 | 25,000 | $421,827.50 | 390,022 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Apr 14 '25 | Sell | $19.10 | 90,000 | $1,718,721.00 | 2,003,100 | |
| Maroney Dawn Christine | ALHC | President | Apr 14 '25 | Sell | $19.10 | 230,000 | $4,392,195.00 | 2,102,899 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Apr 1 '25 | Sell | $18.47 | 25,000 | $461,632.50 | 390,022 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 27 '25 | Sell | $17.89 | 2,864 | $51,236.96 | 702,953 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Mar 27 '25 | Sell | $17.89 | 34,430 | $615,952.70 | 2,003,100 | |
| Freeman Robert Thomas | ALHC | Chief Financial Officer | Mar 27 '25 | Sell | $17.89 | 6,744 | $120,650.16 | 1,464,419 |
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
Simply Wall St.
6 days ago
Institutional investors may overlook Alignment Healthcare, Inc.'s (NASDAQ:ALHC) recent US$348m market cap drop as long-term gains remain positive
GlobeNewswire
11 days ago
Alignment Healthcare to Present at William Blair 45th Annual Growth Stock Conference
Zacks
11 days ago
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
GlobeNewswire
13 days ago
Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality
StockStory
13 days ago
Q1 Rundown: Centene (NYSE:CNC) Vs Other Health Insurance Providers Stocks
StockStory
13 days ago
Q1 Earnings Outperformers: Progyny (NASDAQ:PGNY) And The Rest Of The Health Insurance Providers Stocks
StockStory
16 days ago
ALHC Q1 Earnings Call: Membership Growth and Margin Expansion Drive Upbeat Outlook
Compare ALHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.